Infographics - Avascular Necrosis Market

Avascular necrosis is a disease that results from the short-term or permanent loss of blood supply to the bone. This cut-off of blood supply to bone leads to tiny breaks in the bone and the bones eventually collapse. Avascular necrosis is also known as osteonecrosis. This condition may happen in any bone of the body, but mostly happens in the ends of a long bone. A broken bone or dislocated joint can interrupt the blood flow to a section of bone. Avascular necrosis condition is most common in people between the ages of 30 and 50.

Avascular necrosis can be caused due to-

Injury to bone
Fracture
Damage of blood vessels
Long-term use of medicines, such as corticosteroids
Excessive, long-term use of alcohol

Avascular necrosis can be diagnosed by Bone scan, Magnetic Resonance Image and Computed Tomography, and X-rays. Medications used to treat avascular necrosis are blood thinners, nonsteroidal anti-inflammatory drugs, cholesterol lowering drugs and others.

Market Dynamics

Increasing number of product launches is expected to drive the growth of global avascular necrosis market during the forecast period. For instance, in September 2014, Bayer Healthcare LLC, a pharmaceutical and medicine manufacturing company, announced the launch of Aleve PM, an over-the-counter (OTC) pain reliever product in the U.S.

Increasing number of drug approvals from regulatory bodies is expected to drive the growth of the global avascular necrosis market. For instance, in April 2019, the U.S Food and Drugs Administration approved Evenity (romosozumab-aqqg), a sclerostin inhibitor indicated to treat osteoporosis in postmenopausal women at high risk of breaking a bone.

Key features of the study:

This report provides an in-depth analysis of the global avascular necrosis market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global avascular necrosis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Solara Active Pharma Sciences Limited., Bayer AG, Rochem International, Inc., Alkem Labs., Dwarkesh Pharmaceuticals Private Limited., Novartis AG, GSK, and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global avascular necrosis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global avascular necrosis market

Detailed Segmentation:

Global Avascular Necrosis Market, By Drug Type:
- Nonsteroidal anti-inflammatory drugs
  - Ibuprofen
  - Naproxen Sodium
- Osteoporosis drugs
- Cholesterol- lowering drugs
- Blood Thinners
- Others
Global Avascular Necrosis Market, By Route of Administration:
- Oral
- Injectable
Global Avascular Necrosis Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Avascular Necrosis Market, By Region:
- North America
  - By Drug Type:
    - Nonsteroidal anti-inflammatory drugs
      - Ibuprofen
      - Naproxen Sodium
    - Osteoporosis drugs
    - Cholesterol-lowering drugs
    - Blood Thinners
    - Others
  - By Route of Administration:
    - Oral
    - Injectable
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Drug Type:
    - Nonsteroidal anti-inflammatory drugs
      - Ibuprofen
      - Naproxen Sodium
    - Osteoporosis drugs
    - Cholesterol-lowering drugs
    - Blood Thinners
    - Others
  - By Route of Administration:
    - Oral
    - Injectable
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Drug Type:
    - Nonsteroidal anti-inflammatory drugs
      - Ibuprofen
      - Naproxen Sodium
    - Osteoporosis drugs
    - Cholesterol-lowering drugs
    - Blood Thinners
    - Others
  - By Route of Administration:
    - Oral
    - Injectable
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - By Country:
    - U.K.
    - Germany
    - Italy
    - Spain
    - France
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Drug Type:
    - Nonsteroidal anti-inflammatory drugs
      - Ibuprofen
      - Naproxen Sodium
    - Osteoporosis drugs
    - Cholesterol-lowering drugs
    - Blood Thinners
    - Others
  - By Route of Administration:
    - Oral
    - Injectable
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - By Country:
    - Australia
    - India
    - China
    - Japan
    - ASEAN
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - By Drug Type:
    - Nonsteroidal anti-inflammatory drugs
      - Ibuprofen
      - Naproxen Sodium
    - Osteoporosis drugs
    - Cholesterol-lowering drugs
    - Blood Thinners
    - Others
  - By Route of Administration:
    - Oral
    - Injectable
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Drug Type:
    - Nonsteroidal anti-inflammatory drugs
      - Ibuprofen
      - Naproxen Sodium
    - Osteoporosis drugs
    - Cholesterol-lowering drugs
    - Blood Thinners
    - Others
  - By Route of Administration:
    - Oral
    - Injectable
  - By Distribution Channel:
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Teva Pharmaceuticals Industries Ltd. *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Reddy’s Laboratories Ltd.
- Solara Active Pharma Sciences Limited.
- Bayer AG
- Rochem International, Inc.
- Alkem Labs
- Dwarkesh Pharmaceuticals Private Limited
- Novartis AG
- GSK
- Pfizer, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Route of Administration
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Product Launches/Approvals
- Regulatory Scenario
- Epidemiology
- PEST Analysis
- Acquisition and Collaboration Scenario
Global Avascular Necrosis Market - Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Avascular Necrosis.
- Government Initiative
Global Avascular Necrosis Market, By Drug Type, 2017 – 2028 (US$ Million)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Nonsteroidal anti-inflammatory drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
    - Ibuprofen
    - Naproxen Sodium
- Osteoporosis drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Cholesterol-lowering drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Blood Thinners
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
Global Avascular Necrosis Market, By Route of Administration, 2017 – 2028 (US$ Million)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
    - Ibuprofen
    - Naproxen Sodium
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
Global Avascular Necrosis Market, By Distribution Channel, 2017 – 2028, (US$ Million)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
Global Avascular Necrosis Market, By Region, 2017 – 2028, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, By Region, 2017 – 2028
  - Regional Trends
- North America
  - Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
    - U.S.
    - Canada
- Europe
  - Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of APAC
- Latin America
  - Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Teva Pharmaceuticals Industries Ltd.*
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Dr. Reddy’s Laboratories Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Solara Active Pharma Sciences Limited.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Bayer AG
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Rochem International, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Alkem Labs.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Dwarkesh Pharmaceuticals Private Limited
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - GSK
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Pfizer, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 42 market data tables and 40 figures on "Avascular Necrosis Market” – Global Forecast to 2028”

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount